{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:23:33Z","timestamp":1773923013849,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obstet Gynecol Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13669-016-0178-7","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T03:09:54Z","timestamp":1475464194000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sentinel Lymph Node Mapping in Patients with Endometrial Carcinoma: Less Can Be More"],"prefix":"10.1007","volume":"5","author":[{"suffix":"Jr","given":"Mario M.","family":"Leitao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"178_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"178_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","volume":"134","author":"WM Burke","year":"2014","unstructured":"SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye A, et al. Endometrial cancer: a comprehensive review and current management strategies: part I. Gynecol Oncol. 2014;134:385\u201392.","journal-title":"Gynecol Oncol"},{"key":"178_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","volume":"134","author":"WM Burke","year":"2014","unstructured":"SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye A, et al. Endometrial cancer: a comprehensive review and current management strategies: part II. Gynecol Oncol. 2014;134:393\u2013402.","journal-title":"Gynecol Oncol"},{"key":"178_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer. 1987;60:2035\u201341.","journal-title":"Cancer"},{"key":"178_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55\u201365.","journal-title":"Gynecol Oncol"},{"key":"178_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/gyno.1998.5150","volume":"70","author":"KC Podratz","year":"1998","unstructured":"Podratz KC, Mariani A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol. 1998;70:163\u20134.","journal-title":"Gynecol Oncol"},{"key":"178_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/gyno.1995.1005","volume":"56","author":"LC Kilgore","year":"1995","unstructured":"Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin 3rd F, Conner W. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29\u201333.","journal-title":"Gynecol Oncol"},{"key":"178_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/cncr.22185","volume":"107","author":"JK Chan","year":"2006","unstructured":"Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107:1823\u201330.","journal-title":"Cancer"},{"key":"178_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort study. Lancet. 2010;375:1165\u201372.","journal-title":"Lancet"},{"key":"178_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","volume":"132","author":"S Kumar","year":"2014","unstructured":"Kumar S, Podratz KC, Bakkum-Gamez JN, Dowdy SC, Weaver AL, McGree MA, et al. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol. 2014;132:38\u201343. This is the most comprehensive assessment of the pattern of nodal metastasis in endometrial cancer as it relates to pelvic, para-aortic, and high para-aortic nodal basins.","journal-title":"Gynecol Oncol"},{"key":"178_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"178_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"Writing Committee on behalf of the ASTEC study group","year":"2009","unstructured":"Writing Committee on behalf of the ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised trial. Lancet. 2009;373:125\u201336.","journal-title":"Lancet"},{"key":"178_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"FIGO Committee on Gynecologic Oncology","year":"2009","unstructured":"FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105:103\u20134.","journal-title":"Int J Gynecol Obstet"},{"key":"178_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WLJ, Koper PCM, Lybeert MLM, Jobsen JJ, Warlam-Rodenhuis CC, et al. For the PORTEC group. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet. 2000;355:1404\u201311.","journal-title":"Lancet"},{"key":"178_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. PORTEC Study Group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority randomised trial. Lancet. 2010;375:816\u201323.","journal-title":"Lancet"},{"key":"178_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","volume":"24","author":"ME Randall","year":"2006","unstructured":"Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24:36\u201344.","journal-title":"J Clin Oncol"},{"key":"178_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2011.12.414","volume":"125","author":"KS Tewari","year":"2012","unstructured":"Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;125:87\u201393.","journal-title":"Gynecol Oncol"},{"key":"178_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","volume":"124","author":"KJ Yost","year":"2014","unstructured":"Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, McGRee ME, et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol. 2014;124:307\u201315. First large series of patient-reported lymphedema rates after lymphadenectomy.","journal-title":"Obstet Gynecol"},{"key":"178_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","volume":"125","author":"JN Barlin","year":"2012","unstructured":"Barlin JN, Khoury-Collado F, Kim CH, Leitao Jr MM, Chi DS, Sonoda Y, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125:531\u20135.","journal-title":"Gynecol Oncol"},{"key":"178_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ygyno.2012.08.018","volume":"127","author":"J How","year":"2012","unstructured":"How J, Lau S, Press J, Ferenczy A, Pelmus M, Stern J, et al. Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Onocl. 2012;127:332\u20137.","journal-title":"Gynecol Onocl"},{"key":"178_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ygyno.2011.08.034","volume":"123","author":"S Kang","year":"2011","unstructured":"Kang S, Yoo HJ, Hwang JH, Lim M, Seo S, Park S. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123:522\u20137.","journal-title":"Gynecol Oncol"},{"key":"178_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1470-2045(11)70070-5","volume":"12","author":"M Ballester","year":"2011","unstructured":"Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective mulitcentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469\u201376.","journal-title":"Lancet Oncol"},{"key":"178_CR23","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1245\/s10434-016-5134-2","volume":"23","author":"AG Eriksson","year":"2016","unstructured":"Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, et al. Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery. Ann Surg Oncol. 2016;23:2522\u20138. Large series comparing blue dye vs indocyanine green dye for SLN detection and how obesity impacts detection rates.","journal-title":"Ann Surg Oncol"},{"key":"178_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/IGC.0b013e3182954da8","volume":"23","author":"CH Kim","year":"2013","unstructured":"Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Barlin JN, et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer. 2013;23:964\u201370. Detailed description of the MSKCC pathologic SLN ultrastaging protocol.","journal-title":"Int J Gynecol Cancer"},{"key":"178_CR25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ygyno.2013.09.027","volume":"131","author":"CH Kim","year":"2013","unstructured":"Kim CH, Khoury-Collado F, Barber EL, Soslow RA, Makker V, Leitao Jr MM, et al. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. Gynecol Oncol. 2013;131:714\u20139.","journal-title":"Gynecol Oncol"},{"key":"178_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ygyno.2013.01.002","volume":"129","author":"MM Leitao Jr","year":"2013","unstructured":"Leitao Jr MM, Khoury-Collado F, Gardner G, Sonoda Y, Brown CL, Alektiar KM, et al. Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol. 2013;129:38\u201341.","journal-title":"Gynecol Oncol"},{"key":"178_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ygyno.2015.12.028","volume":"140","author":"AGZ Eriksson","year":"2016","unstructured":"Eriksson AGZ, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol. 2016;140:394\u20139. First comparison of SLN mapping and historic selective lymphadenectomy algorithms for endometrial cancer.","journal-title":"Gynecol Oncol"},{"key":"178_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ygyno.2015.04.008","volume":"138","author":"O Touhami","year":"2015","unstructured":"Touhami O, Trinh X, Gregoire J, Sebastianelli A, Renaud M, Grondin K, Plante M. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. Gynecol Oncol. 2015;138:41\u20135. Prospective assessment of risk of metastasis to non-SLNs in SLN mapped cases.","journal-title":"Gynecol Oncol"},{"key":"178_CR29","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1245\/s10434-015-5040-z","volume":"23","author":"CM St. Clair","year":"2016","unstructured":"St. Clair CM, Eriksson AGZ, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, et al. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol. 2016;23:1653\u20139.","journal-title":"Ann Surg Oncol"},{"key":"178_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2007.14.5920","volume":"26","author":"LK Tan","year":"2008","unstructured":"Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol. 2008;26:1\u201311.","journal-title":"J Clin Oncol"},{"key":"178_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M Boer de","year":"2009","unstructured":"de Boer M, van Deurzen CHM, van Dijck JAAM, Borm GF, van Diest PJ, Adang EMM, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009;361:653\u201363.","journal-title":"N Engl J Med"},{"key":"178_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3802\/jgo.2016.27.e1","volume":"27","author":"Y Todo","year":"2016","unstructured":"Todo Y, Kato H, Okamoto K, Minobe S, Yamashiro K, Sakuragi N. Isolated tumor cells and micrometastases in regional lymph nodes in stage I and II endometrial cancer. J Gynecol Oncol. 2016;27:e1.","journal-title":"J Gynecol Oncol"}],"container-title":["Current Obstetrics and Gynecology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13669-016-0178-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13669-016-0178-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13669-016-0178-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:35:39Z","timestamp":1581968139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13669-016-0178-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1007\/s13669-016-0178-7","relation":{},"ISSN":["2161-3303"],"issn-type":[{"value":"2161-3303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"assertion":[{"value":"3 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mario M. Leitao, Jr. declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This research was funded in part through the NIH\/NCI Cancer Center Support Grant P30 CA008748.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}